Prawo i regulacje · 28/01/2003
MDI Pharmaceuticals Revocation of Registration
MDI Pharmaceuticals Revocation of Registration
Source: Federal Register — Justice DepartmentOpen original release →
LATEST SIGNALS
6Prawo i regulacje · 9/14/2026
Notice of Lodging of Proposed Stipulation and Order of Settlement Under the Toxic Substances Control Act
Notice of Lodging of Proposed Stipulation and Order of Settlement Under the Toxic Substances Control Act
Read summary →Prawo i regulacje · 9/14/2026
Notice of Lodging of Proposed Final Supplemental Consent Decree Under the Clean Water Act
Notice of Lodging of Proposed Final Supplemental Consent Decree Under the Clean Water Act
Read summary →Prawo i regulacje · 9/14/2026
Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc.
Cambrex High Point, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Read summary →Prawo i regulacje · 9/14/2026
Importer of Controlled Substances Application: Irvine Labs, Inc.
Irvine Labs, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Read summary →Prawo i regulacje · 9/11/2026
Agency Information Collection Activities; Proposed eCollection eComments Requested; Reinstatement, With Change, of a Previously Approved Collection, for Which Approval Has Expired: Title-2026 National Survey of Victim Service Providers
The Bureau of Justice Statistics (BJS), Department of Justice (DOJ) will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Read summary →Prawo i regulacje · 9/11/2026
Craig Cohen, DPM; Decision and Order
Craig Cohen, DPM; Decision and Order
Read summary →